A comparative study of preclinical and clinical molecular imaging response to EGFR inhibition using osimertinib in glioblastoma is a research paper published in Neuro-Oncology Advances (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
AstraZeneca
Grant: NIH/NCI P50CA211015
DAN, TFC, BME
Grant: R01CA279984
U.S. Department of Defense
Grant: CDMRP CA220732
NCI NIH HHS
Grant: P50 CA211015
NCI NIH HHS
Grant: P30 CA016042
National Institutes of Health
Grant: 5P50CA211015-02
UCLA SPORE in Brain Cancer
National Institutes of Health
Grant: 5R01CA279984-03
Quantitative molecular MR-PET imaging of glycolysis in glioblastoma
NCI
NIH
FWCI
0.73
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords